Klow 80mg

Klow is a proprietary four-peptide repair blend combining BPC-157 (pentadecapeptide cytoprotection and angiogenesis), TB-500 (Thymosin Beta-4 fragment actin remodelling), KPV (alpha-MSH C-terminal tripeptide immune modulation) and GHK-Cu (copper tripeptide collagen and gene-expression modulation). The composite formulation is studied as a combined-mechanism reference for tissue repair, inflammatory resolution and extracellular matrix research where parallel pathway engagement is of methodological interest.

Supplied as a lyophilised peptide vial, supplied for reconstitution with bacteriostatic water. The 80mg total presentation suits combined-mechanism repair protocols, multi-pathway characterisation studies and laboratories investigating peptide-stack synergy across angiogenic, cytoskeletal, immune and collagen-synthesis endpoints.

Research Applications • Combined tissue repair and multi-pathway regeneration model studies • Parallel angiogenic, actin-remodelling and collagen synthesis assays • Immune modulation and inflammatory resolution pathway research • Peptide-stack synergy and combined-mechanism characterisation

Specification • Identity: BPC-157 + TB-500 + KPV + GHK-Cu blend (80mg total) • Molecular weight: varies by component • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.